INTRODUCTION {#sec1-1}
============

HMB has been objectively described as "the loss of 80 ml or more blood during every menstrual cycle" in the 1960s.[@ref1] This definition has been changed by the NICE in the United Kingdom in 2007 to "excessive menstrual blood loss that physically, emotionally, socially and financially affects the QoL of women and can be seen by itself or with other symptoms" to include the above definition.[@ref2] Reported HMB prevalence in women varies between 27.2% and 54.0%[@ref3]-[@ref9], making it a common disorder. The cause of HBM can be fibroids and polyps, adenomyosis, irregular ovulation, bleeding disorders, drugs, cancer and other etiologic factors.[@ref10] HMB has been shown to have negative effects on the psychological state, energy, work productivity, social relationships, family life and sexual functions of women.[@ref4],[@ref11],[@ref12] Besides, the excessive blood loss during the menstrual period can cause physical health problems such as iron deficiency anemia (IDA) and fatigue.[@ref6],[@ref13],[@ref14]

Fatigue and IDA developing due to excessive menstrual bleeding affects the QoL of women negatively.[@ref4] Besides, HMB itself is also reported to have the potential to cause problems.[@ref4],[@ref11],[@ref12] It was emphasized in a study that the woman's experience with blood loss and the effect on her life should be identified when planning the treatment of abnormal uterine bleeding.[@ref11] We therefore aimed to find the prevalence of HMB in women of reproductive age and to evaluate the effects of this problem on anemia, fatigue and the QoL.

METHODS {#sec1-2}
=======

This descriptive and sectional study was conducted with women in the age group of 15-49 years who presented to the internal medicine outpatient departments of the training and research hospital of a university between 15.01-02.04.2018 to be examined. It was not possible to determine how many women aged 15-49 years had presented to the outpatient departments for examination from the automation system of the study hospital so we used the sample size from unknown population when selecting the sample. Using the sample size from unknown population formula with a 95% confidence interval and p-value of 0.272[@ref3], the minimum number of women required in the sample was calculated as 304.

Study inclusion criteria were women in the age group of 15-49 years who consented to participate in the study and could understand and answer the questions besides having regular menstrual periods.

The study was completed with 306 women who met the above criteria. After the necessary permissions were obtained, data collection tools were administered to the women with the face-to-face interview method by the investigators and a trained pollster at the internal medicine outpatient department of the hospital where the study was conducted.

The data were collected with the "Data Collection Form" created by the investigators after evaluating the relevant literature[@ref3],[@ref7],[@ref13],[@ref15], the "SF-36 QoLS and the BFI. The data collection form included a total of 22 questions regarding the women's socio-demographic characteristics, menstrual features and other risk factors in addition to the hemoglobin and serum ferritin level. The presence of HMB was defined as menstruation continuing for more than 7 days[@ref16] and according to the criteria used by Fraser et al.[@ref3] in their study.

The SF-36 QoLS was developed in 1987 by Ware to be used in the investigation of the health-related QoL. This scale contains 36 items and includes two main titles and eight subdimensions. This scale has positive scoring and the QoL of the individual increases as the score obtained in each health area increases.[@ref17]

The BFI was developed by the MD Anderson Cancer Center in order to identify the level of fatigue. This inventory includes the general fatigue level and the level of interference with daily activities within the past 24 hours. A score of "0" from the BFI shows that fatigue does not affect the individual, "1-3" a low level, "4-6" a moderate level, "7-9" a high level, and "10" the highest level.[@ref18]

This study was started after obtaining approval from the Nigde Omer Halisdemir University Ethics Committee and written permission from hospital where the study was conducted. Before administering the data collection tools, the aim of the study was explained to women aged 15-49 years and they were asked to voluntarily participate in the study. Verbal and written informed consent was obtained from the women who accepted to participate.

Statistical Analysis {#sec2-1}
--------------------

The study data were evaluated by using the SPSS IBM (24.0) software. Descriptive statistics, t-test and Mann-Whitney U-test were used for data analysis. The Spearman Correlation test was used in the evaluation of the relationship between menstruation duration and hemoglobin and serum ferritin levels, fatigue and QoL. A *p* value of \<0.05 was considered significant.

RESULTS {#sec1-3}
=======

The mean age of the women and at menarche (years) was 30.8±9.7 and 13.4±1.4 respectively. The menstruation duration was 8 or more days in 15.4% of the women. We found that 54.9% were using more than 12 pads during one menstrual period and 13.1% were experiencing intense menstrual bleeding of 4 days or longer. Large clot passage during menstruation was present in 66.3%. Besides, 27.1% expressed that they used double pads, 53.3% often replaced the pad to avoid blood overflow, and 8.2% had intermittent bleeding. Using our study criteria, the prevalence of HMB was 37.9% in the female population. We found that 24.1% of the women perceived the bleeding they experienced during menstruation as heavy or very heavy ([Table-I](#T1){ref-type="table"}).

###### 

Menstrual features of women.

  Menstruation Related Features                                               n     \%
  --------------------------------------------------------------------------- ----- ------
  *Age at menarche* (X̄*±SD=13.4±1.4) (Min-Max=9-18)*                                
  ≤11                                                                         20    6.5
  12-14 years                                                                 223   72.9
  ≥ 15 years                                                                  63    20.6
  *Duration of menstruation* (X̄*±SD=6.15±1.8) (Min-Max=1-12)*                       
  ≤ 4 days                                                                    45    14.7
  5-7 days                                                                    214   69.9
  ≥8 days                                                                     47    15.4
  *Menstrual cycle duration* (X̄*±SD=26.7±6.3) (Min-Max=10-60)*                      
  \<21 days                                                                   40    13.1
  21-35 days                                                                  253   82.7
  \>35 days                                                                   13    4.2
  *Number of pads used in one cycle* (X̄*±SD=13.7±9.6) (Min-Max=1-100)*              
  ≤11 pads                                                                    138   45.1
  ≥12 pads                                                                    168   54.9
  *The number of days when menstruation is heavy*                                   
  Never                                                                       7     2.2
  1 day                                                                       21    6.9
  2 days                                                                      119   38.9
  3 days                                                                      119   38.9
  ≥ 4 days                                                                    40    13.1
  *Large clot passage during menstruation*                                          
  Yes                                                                         203   66.3
  No                                                                          103   33.7
  *Use of double pads during menstruation*                                          
  Yes                                                                         83    27.1
  No                                                                          223   72.9
  *Frequent replacement of pads for menstrual bleeding to prevent overflow*         
  Yes                                                                         163   53.3
  No                                                                          143   46.7
  *Intermittent bleeding*                                                           
  Yes                                                                         25    8.2
  No                                                                          281   91.8
  *Presence of HMB meeting criteria*                                                
  Yes                                                                         116   37.9
  No                                                                          190   62.1
  *Severity of menstrual bleeding as perceived by women*                            
  Mild                                                                        47    15.4
  Moderate                                                                    185   60.5
  Heavy                                                                       50    16.3
  Very heavy                                                                  24    7.8

Anemia diagnosis was present in 63.4% of the women in our study; 33.0% reported that they had used an iron preparation in the last three months and 16.7% were still using it. The mean hemoglobin amount and serum ferritin levels in women of reproductive age were 13.41±1.3 g/dL and 32.76±8.0 ng/mL, respectively. Besides, 14.0% of the women had a hemoglobin level of \<12 g/dL and 17.3% had a serum ferritin level under 7 ng/mL.

The median hemoglobin and ferritin levels of the HMB group were found to be statistically significantly lower than the group without HMB (*p\<*0.05). A statistically significant relationship was found between HMB presence and the median general fatigue and interference with daily activities scores (*p\<*0.05). The QoL was found to be higher in the physical functioning and role limitation (physical and emotional) subdimensions but lower in the bodily pain subdimension of the SF-36 QoLS in women without HMB than those with HMB (*p\<*0.05). No statistically significant relationship was found between HMB presence and the other subdimensions of SF-36 QoLS (*p\>0.05*) ([Table-II](#T2){ref-type="table"}).

###### 

Presence of HMB according to the Hemoglobin and Ferritin Levels, and the BFI and SF-36 QoLS Subdimension Scores

  ------------------------------------------------------------------------------------------------------------------------------
                                                                       Presence of HMB                               
  -------------------------------------------------------------------- ----------------- ------- ----------- ------- -----------
  Hemoglobin[\*](#t2f1){ref-type="table-fn"}                           13.05±1.4         13.25   13.64±1.2   13.85   Z=-3.896\
                                                                                                                     p\<0.0001

  Ferritin[\*](#t2f1){ref-type="table-fn"}                             23.36±4.0         11.45   38.50±9.7   19.65   Z=-3.999\
                                                                                                                     p\<0.0001

  *Brief Fatigue Level*                                                                                              

  General Fatigue Level[\*](#t2f1){ref-type="table-fn"}                6.19±2.3          6.50    5.07±2.6    5.33    Z=-3.564\
                                                                                                                     p\<0.0001

  Interference with Daily Activities[\*](#t2f1){ref-type="table-fn"}   4.20±2.6          4.33    3.55±2.8    3.08    Z=-2.258\
                                                                                                                     p=0.024

  *SF-36 QoLS Subdimensions*                                                                                         

  SF-36 Physical Functioning[\*](#t2f1){ref-type="table-fn"}           73.58±2.5         82.50   80.24±2.1   85.00   Z=-2.438\
                                                                                                                     p=0.015

  SF-36 Role Limitation-Physical[\*](#t2f1){ref-type="table-fn"}       51.94±4.0         50.00   64.21±1.2   75.00   Z=-2.720\
                                                                                                                     p=0.007

  SF-36 Bodily Pain[\*](#t2f1){ref-type="table-fn"}                    41.55±2.4         40.00   35.58±2.5   30.00   Z=-2.040\
                                                                                                                     p=0.041

  SF-36 General Health Perception[\*](#t2f1){ref-type="table-fn"}      52.76±1.3         50.00   52.13±1.2   50.00   Z=-0.567\
                                                                                                                     p=0.571

  SF-36 Energy/ Vitality[\*](#t2f1){ref-type="table-fn"}               49.74±1.2         50.00   48.71±1.4   50.00   Z=-1.035\
                                                                                                                     p=0.301

  SF-36 Mental Health[\*](#t2f1){ref-type="table-fn"}                  46.86±1.3         48.00   48.51±1.4   48.00   Z=-1.149\
                                                                                                                     p=0.251

  SF-36 Role Limitation-Emotional[\*](#t2f1){ref-type="table-fn"}      51.44±4.4         66.67   65.09±4.1   83.33   Z=-2.695\
                                                                                                                     p=0.007

  SF-36 Social Functioning[\*](#t2f1){ref-type="table-fn"}             45.80±1.5         50.00   47.83±1.5   50.00   Z=-1.190\
                                                                                                                     p=0.234

  SF-36 Physical Component Summary[\*](#t2f1){ref-type="table-fn"}     36.43±6.8         37.03   37.93±6.8   38.52   Z=-1.767\
                                                                                                                     p=0.077

  SF-36 Mental Component Summary[\*\*](#t2f2){ref-type="table-fn"}     43.09±6.4         43.39   43.70±5.6   43.51   t=-0.878\
                                                                                                                     p=0.266
  ------------------------------------------------------------------------------------------------------------------------------

Mann-Whitney U test,

Independent Samples t test

According to the Spearman's correlation analysis conducted, the ferritin level slightly decreased and the fatigue levels increased in women as the menstruation level increased (*p\<*0.05). We found a weak negative significant relationship between the menstruation duration and the physical functioning subdimension of SF-36 QoLS and a weak positive significant relationship between the menstruation duration and the general health perception subdimension (*p\<*0.05). No statistically significant relationship was found between the menstruation duration and the other subdimensions of SF-36 QoLS than physical functionality and general health perception (*p\>0.05*) ([Table-III](#T3){ref-type="table"}).

###### 

The Relationship between the Hemoglobin and Ferritin Levels, SF-36 QoLS Subdimensions, Components of the BFI, and Menstruation Duration.

                                       Menstruation Duration   
  ------------------------------------ ----------------------- -------
  Hemoglobin                           -0.100                  0.080
  Ferritin                             -0.121                  0.035
  *SF-36 QoLS Subdimensions*                                   
  SF-36 Physical Functioning           -0.144                  0.011
  SF-36 Role Limitation-Physical       -0.104                  0.070
  SF-36 Bodily Pain                    0.089                   0.121
  SF-36 General Health Perception      0.156                   0.006
  SF-36 Energy/ Vitality               0.102                   0.074
  SF-36 Mental Health                  0.042                   0.466
  SF-36 Role Limitation-Emotional      -0.044                  0.444
  SF-36 Social Functioning             -0.028                  0.630
  SF-36 Physical Component Summary     0.042                   0.467
  SF-36 Mental Component Summary       -0.085                  0.139
  *BFI*                                                        
  General Fatigue Level                0.157                   0.006
  Interference with Daily Activities   0.114                   0.047

DISCUSSION {#sec1-4}
==========

HMB was found to be present in approximately 4 of 10 (37.9%) women of reproductive age in our study ([Table-III](#T3){ref-type="table"}). This rate was reported as 27.2% in women aged 16-57 years living in five European regions in a study on the prevalence of HMB using similar criteria.[@ref3] The prevalence of heavy menstruation was found to be 32% in the study conducted by Karlsson et al.[@ref4] among women aged 40-45 years in Sweden. This prevalence was found to be lower at 15.2% in a study conducted among women aged 15-45 years in Iran.[@ref8] There is no previous study on the prevalence of HMB in women of reproductive age in our country, but the prevalence of HMB was 21.8% in a study conducted on university students.[@ref9] The higher prevalence of HMB in our study compared to other studies[@ref3],[@ref9] on women in a similar age group could be due to the difference sample population and data collection method and also because the subjects presenting at the internal medicine outpatient departments for the follow-up and treatment of anemia that could be the result of heavy menstruation.

Despite the various definitions of HMB[@ref1],[@ref5],[@ref16], it is emphasized that the perception of this condition by women should also be investigated.[@ref16] The menstrual bleeding was thought to be heavy or very heavy in 24.1% of the women in our study ([Table-I](#T1){ref-type="table"}). An Australian study reported that 27.8% of the women aged 20-39 years perceived their menstrual bleeding as heavy or very heavy.[@ref19] Our finding is similar to that reported by Weisberg, McGeehan, Fraser.[@ref19]

HMB can therefore cause a decrease in iron level and hemoglobin amount and lead to anemia in women if not treated.[@ref20]Anemia was found to be present in two third of women who had HMB in the study of Fraser et al.[@ref3] The presence of HMB and the relationship between hemoglobin and serum ferritin in women were investigated according to the two parameters of the hemoglobin amount and serum ferritin level used for the detection of anemia in our study. The median hemoglobin amount and ferritin levels of women who were found to have HMB were significantly lower than those without heavy bleeding (*p\<0*.0001). Our results are similar to those reported in the literature.[@ref1],[@ref3],[@ref20] Besides, the ferritin level was found to decrease mildly as the menstruation duration increased in our study. The lack of or weak correlation between the hemoglobin amount and ferritin level and menstruation duration in our study could be due to two thirds of the women in the sample having used iron preparations in the last three months.

HMB can cause fatigue in addition to iron deficiency in women.[@ref6],[@ref13],[@ref14] Fatigue (90.4%) was reported to be one of the main symptoms in women in the study conducted by Fraser et al.[@ref3] Similarly, Wang et al.[@ref14] found the fatigue to be one of the most common symptoms in young women with HMB in their study. The median general fatigue level (*p\<*0.0001) and interference with daily activities (*p=*0.024) scores of women with HMB were found to be significantly higher than those without HMB in our study. Besides, a very weak positive relationship was found between the menstruation duration and the general fatigue level (*p*=0.006) and the level of interference with daily activities (*p*=0.047). Our results are consistent with the above-mentioned literature.[@ref3],[@ref6],[@ref13],[@ref14]

HMB itself [@ref4],[@ref11],[@ref12] and the anemia and fatigue developing due to the bleeding[@ref4] are reported to decrease the QoL in women. However, it is not clear how the symptoms caused by HBM affect the QoL in women.[@ref21] The QoL in the physical functioning and role limitation (physical and emotional) subdimensions of the SF-36 QoLS was found to be significantly low in presence of HBM in women in our study (*p\<*0.05). Besides, the median physical and mental component summary scores of QoLS of SF-36 decreased in the presence of HMB, although not statistically significant. The QoL in all subdimensions of SF-36 QoLS was found to decrease in women with HMB compared to those with normal menstruation in the study of Karlsson et al.[@ref4] A statistically significant difference in all the subdimensions of SF-36 was found between the women with menorrhagia and the control group in a case control study conducted in our country.[@ref15]

We also found a weak negative correlation between menstruation duration and the physical functioning subdimension of SF-36 QoLS and also a weak positive correlation between menstruation duration and the health perception subdimension in our study. However, no significant relationship was found between menstruation duration and the SF-36 QoLS physical and mental component summary scores. The limitation in physical and social/leisure time activities was found to increase as the daily blood loss increased in women in the study conducted by Lukes et al.[@ref21] De Souza et al.[@ref22] found no significant relationship between the menstruation amount and the SF-36 QoLS physical and mental component in their study. The lack of a significant relationship between any subdimension of the QoL and menstruation duration in our study could be due to the majority of the women using an iron preparation for anemia. This view is supported by our finding that the hemoglobin amount of women and their physical and mental component summary scores of QoLS in SF-36 increased significantly after treatment in the study of de Souza et al.[@ref22]

CONCLUSION {#sec1-5}
==========

HMB is common in women and was found to decrease the hemoglobin and serum ferritin levels used in evaluating anemia, increase the fatigue level, and affect the physical and role limitation (physical and emotional) subdimensions of the QoL negatively in our study. We believe that the negative effects on anemia, fatigue and QoL caused by this problem can be prevented and treatment plans can be identified by querying HMB in all women of reproductive age who present for examination and by performing regular follow-ups. We recommend investigating the effects of HMB on anemia, fatigue and QoL by checking the use of iron preparations in future studies.
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